Sign inJoin waitlistJoin the waitlist

Brian Hill

Director, Lymphoid Malignancies Program · Cleveland Clinic Foundation

Credentials: · · · ·

History

Lymphoid Malignancies Program · Cleveland Clinic Foundation
Present
Case Western Reserve University
Present

Cleveland Clinic
2008–2011
Internal Medicine
University of Chicago Medical Center
2005–2008
Stony Brook University
University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine
2001–2005
Dartmouth College
1992–1996

Research

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
New England Journal of Medicine · 2017 · 4,914 citations
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial
The Lancet Oncology · 2019 · 1,921 citations
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
New England Journal of Medicine · 2020 · 1,512 citations

Robert Dean
56 papers
Matt Kalaycio
52 papers
BP
Brad Pohlman
49 papers
Deepa Jagadeesh
47 papers
Ronald Sobecks
44 papers
NM
Navneet Majhail
38 papers
Betty Hamilton
34 papers · 2 as a fellow
BB
Brian Bolwell
34 papers
Mazyar Shadman
33 papers
Paolo Caimi
29 papers
Allison Winter
28 papers · 13 as a resident
HL
Hien Liu
27 papers

Clinical trials

Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant
Principal investigator · Completed · Early phase 1
Case Comprehensive Cancer Center
2014–2015